RNAC - Cartesian Therapeutics Inc
9.02
2.170 24.058%
Share volume: 2,923,114
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$6.85
2.17
0.32%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-08-2024 | 11-07-2024 | 03-13-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | |
| Cash flow financing | 43.031 M | 120.000 K | 124.494 M | 783.000 K | -8.025 M | 60.000 K | -38.000 K | |
| Other financing cash flows | 0.000 | 120.000 K | 56.000 K | 849.000 K | 183.000 K | 85.000 K | 5.000 K | |
| Cash flow | -15.917 M | -15.913 M | 131.986 M | -6.573 M | -32.208 M | -20.056 M | -16.930 M | |
| Net income | -56.824 M | 13.836 M | -24.183 M | -10.253 M | -17.710 M | 15.886 M | -35.902 M | |
| Depreciation | 183.000 K | 196.000 K | 286.000 K | 486.000 K | 1.156 M | 589.000 K | 606.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 4.376 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -602.000 K | -1.587 M | -6.199 M | -354.000 K | -1.075 M | -2.595 M | -1.292 M | |
| Net Borrowings | -96.276 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | -7.754 M | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -602.000 K | 1.587 M | 6.199 M | 705.000 K | 1.075 M | 2.595 M | 1.292 M | |
| Cash Change | 103.418 M | -15.899 M | 131.971 M | -6.588 M | -32.176 M | -20.044 M | -16.940 M |